Registration - Amendment
INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH for INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH
Income
—
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Regulation of stem cell-based therapies, funding for biomedical research, regulation of stem cell research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC D ANTHONY New | Legislative Director, Congresswoman Rosa L. DeLauro, Legislative Assistant, Congressman Anthony Weiner |
| MEGAN DONOVAN New | — |
Science/Technology SCI
Regulation of stem cell-based therapies, funding for biomedical research, regulation of stem cell research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC D ANTHONY New | Legislative Director, Congresswoman Rosa L. DeLauro, Legislative Assistant, Congressman Anthony Weiner |
| MEGAN DONOVAN New | — |
Health Issues HCR
Regulation of stem cell-based therapies, funding for biomedical research, regulation of stem cell research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC D ANTHONY New | Legislative Director, Congresswoman Rosa L. DeLauro, Legislative Assistant, Congressman Anthony Weiner |
| MEGAN DONOVAN New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.